Keywords: eisai, genpharm, joint, venture, announced, international, co-develop

EISAI GENPHARM JOINT VENTURE

Article | 19 July 1993

- Eisai has announced a joint venture with Genpharm International to co-develop human monoclonal antibodies from transgenic mice for therapeutic use. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Eisai

Go to company listing